The treatment of hypertension in patients with erectile dysfunction

被引:25
|
作者
Mikhailidis, DP
Khan, MA
Milionis, HJ
Morgan, RJ
机构
[1] UCL Royal Free & Univ Coll Med Sch, Dept Mol Pathol & Clin Biochem, London NW3 2QG, England
[2] UCL Royal Free & Univ Coll Med Sch, Dept Urol, London NW3 2QG, England
关键词
beta-blockers; diuretics; doxazosin; erectile dysfunction; hypertension;
D O I
10.1185/0300799009117037
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Hypertension is another predictor of erectile dysfunction (ED). This is further evidence supporting a link between the pathogenesis of atherosclerotic disease ann ED. In one study (TOMHS) involving hypertensive patients, the incidence of ED was 14.4%. The drugs used to treat hypertension may cause ED. However, there is little trial-based evidence to indicate which drugs are more likely to cause this side effect. In general, thiazide diuretics and beta-blockers seem to cause ED more often. In contrast, the alpha-blocker doxazosin, has Mot been associated with an increased incidence of ED as a sine effect. Doxazosin also improves urinary flow in patients with benign prostatic hyperplasia (BPH). This condition is common in elderly men as is hypertension and ED. Therefore, doxazosin may present a special advantage among this group of patients. This alpha-blocker would also be a good choice in patients with impaired glucose tolerance/diabetes because it improves insulin sensitivity. Moreover, ED and hypertension are more prevalent among diabetics. On a more speculative note, doxazosin may potentiate the therapeutic impact of specific treatments for ED.
引用
收藏
页码:S31 / S36
页数:6
相关论文
共 50 条
  • [21] Treatment of Urinary Incontinence in Patients With Erectile Dysfunction
    Ajay, Divya
    Mendez, Melissa H.
    Wang, Run
    Westney, O. Lenaine
    SEXUAL MEDICINE REVIEWS, 2021, 9 (04) : 593 - 604
  • [22] Improving treatment of erectile dysfunction in cardiac patients
    Rebecca Ireland
    Nature Clinical Practice Urology, 2005, 2 (9): : 408 - 408
  • [23] HYPERTENSION AND ERECTILE DYSFUNCTION: NEW INSIGHTS IN HEART FAILURE PATIENTS
    Koutsampasopoulos, K.
    Imprialos, K.
    Stavropoulos, K.
    Katsimardou, A.
    Patoulias, D.
    Sachinidis, A.
    Petidis, K.
    Bouloukou, S.
    Kerpiniotis, G.
    Athyros, V.
    Karagiannis, A.
    Doumas, M.
    JOURNAL OF HYPERTENSION, 2019, 37 : E118 - E118
  • [24] Clinically important difference on the Erectile Dysfunction Inventory of Treatment Satisfaction questionnaire in patients with erectile dysfunction
    Cappelleri, Joseph C.
    Tseng, Li-Jung
    Stecher, Vera J.
    Althof, Stanley E.
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2018, 72 (04)
  • [25] Treatment of erectile dysfunction
    Dinsmore, W
    INTERNATIONAL JOURNAL OF STD & AIDS, 2004, 15 (04) : 215 - 221
  • [26] Treatment of erectile dysfunction
    Opsomer, RJ
    ACTA CLINICA BELGICA, 2002, 57 (05) : 272 - 276
  • [27] The Treatment of Erectile Dysfunction
    Gambescia, Nancy
    Sendak, Shelley
    Weeks, Gerald
    JOURNAL OF FAMILY PSYCHOTHERAPY, 2009, 20 (2-3) : 221 - 240
  • [28] Treatment of erectile dysfunction
    Ahmed-Jushuf, IH
    Griffiths, V
    Hall, J
    Gregory, A
    INTERNATIONAL JOURNAL OF STD & AIDS, 2004, 15 (09) : 639 - 639
  • [29] Treatment of Erectile Dysfunction
    Engelmann, U
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2005, 130 (05) : 230 - 230
  • [30] Hypertension, antihypertensive therapy, and erectile dysfunction
    Papatsoris, AG
    Korantzopoulos, PG
    ANGIOLOGY, 2006, 57 (01) : 47 - 52